Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication intimating the shareholders that the 44th Annual General Meeting of the Company will be held on Tuesday, August 30, 2022 at 11.00 AM (IST) through Video Conferencing / Other Audio Visual Means. Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call Transcript for Q1FY23 Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Investor meetings
Easing of supply chain constraints may soothe Gland Pharma's pain
High costs and the absence of big launches in FY23 would come in the way of a significant margin improvement
Results Earnings Call for Q1FY23 of Gland Pharma
Conference Call with Gland Pharma Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript. Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement pertaining to Unaudited Financial Results of Q1FY2023